Catherine Parr specializes in guiding organizations through complex transformations, particularly within the pharmaceuticals, biotech and MedTech sectors. As a consultant in the Healthcare Practice, she is known for connecting strategic vision with leadership to shape the future of life sciences. Catherine is recognized for her ability to translate intricate problems into actionable leadership decisions and has supported clients in making confident strategic and execution choices in cross-border contexts, particularly between Japan and international markets, shaping the direction of their organizations.
Catherine believes that in life sciences, leadership decisions extend beyond business performance to influence patient outcomes and scientific progress. She uncovers the drivers of organizational effectiveness and helps leaders activate them, especially during times of transformation, when choices at the top can redefine a company’s future.
Connecting strategic vision with leadership to shape the future of life sciences
- As a principal at L.E.K. Consulting in Tokyo, Catherine led planning and execution of cross-border APAC strategy projects and commercial due diligence for global pharma and private equity firms.
- In addition, she managed large-scale 2030 growth strategies for MNC big pharma and led commercial assessments for ex-Japan biopharma market entry.
- Earlier in her career, as a consultant at IQVIA, she delivered global strategic projects focused on pricing, market access and commercial strategy across global markets, including Europe, the U.S. and China.
Catherine holds a B.A. in physiological sciences from the University of Oxford, specializing in neuroscience.